Latest Industry Press Releases More...

We bring you the latest pharmaceutical press releases in our pharmaceutical Industry Press Releases section to help our clients gain great exposure on industry happenings. Know about mergers, deals, technology release, and other information first hand from press conferences of industry leaders with our Global pharmaceuticals Industry Press Releases.

ANI Pharmaceuticals, Inc. announced it has received approval of the Company's abbreviated new drug application (ANDA) from the U.S. Food and Drug Administration (FDA) for Potassium Citrate Extended-Release Tablets USP, 10 mEq and 15 mEq.  The current annual U.S. market for this product is approximately $75 million, according to IQVIA.…

Twist Bioscience Corporation, a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, announced today a collaboration with Schrödinger, Inc., a company focused on transforming the way therapeutics are discovered with a physics-based computational platform, to bring the two companies’ technology platforms together…

Syntegon Technology is the new name among the market leaders in the processing and packaging industry. Known as Bosch Packaging Technology until late 2019, the former Bosch division today presented itself as an independent enterprise at the company headquarters inWaiblingen (Germany). Syntegon Technology’s business focus is on intelligent and sustainable…

Iovance Biotherapeutics, Inc., an advanced phase biotechnology company developing new T-cell based cancer immunotherapies, and Cellectis, a clinical phase biopharmaceutical company specializing in the development of immunotherapies based on genetically modified allogeneic CAR-T cells (UCART), have announced the signing of a research partnership and an exclusive global license agreement granting…

Aro Biotherapeutics Company announces it has entered a licensing and collaboration agreement with Ionis Pharmaceuticals, Inc., the leader in RNA-targeted therapeutics, through which Ionis will use Aro’s CENTYRIN™ technology to develop targeted cell- and tissue- specific delivery of antisense oligonucleotides (ASOs). Under the terms of the agreement, the companies will…

Empirico Inc. announced today that it has entered into a strategic collaboration with Ionis Pharmaceuticals. During the three-year collaboration, Empirico will utilize its Precision Insights Platform, which incorporates huge biological data sets, human genetics and advanced algorithmic approaches, to identify therapeutic targets for indications and tissues that are amenable to…

Candel Therapeutics, a leader in developing viral immunotherapies across multiple tumor indications, announced today that it has acquired all oncolytic and other Herpes Simplex Virus (HSV) based assets from PeriphaGen, Inc., bringing its vector engineering, production expertise and next-generation HSV drug development platform in-house. This acquisition solidifies Candel's viral therapy…

AXIM® Biotechnologies, Inc., a world leader in cannabinoid research and development, announced today that the Company has signed a binding term sheet to acquire leading oncology research and development company Sapphire Biotech, Inc. (“Sapphire”) as a wholly-owned subsidiary. AXIM and Sapphire intend to enter into Definitive Documents for the transaction…

MiNA Therapeutics, the pioneer in RNA activation therapeutics, announced today the initiation of a research collaboration with AstraZeneca to evaluate small activating RNA ("saRNA") molecules in metabolic diseases. The collaboration combines MiNA's leading expertise in the discovery and development of saRNA therapeutics with AstraZeneca's experience in identifying and bringing breakthrough…

HOOKIPA Pharma Inc., a company developing a new class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform, today announced that HOOKIPA has made strong progress in its collaboration with Gilead for novel arenavirus-based therapeutics intended to support functional cures for chronic Hepatitis B virus (HBV)…

loader